Down‐Regulation of Angiotensin II Receptor Subtypes and Desensitization of Cyclic GMP Production in Neuroblastoma N1E‐115 Cells

Abstract

Murine neuroblastoma N1E-115 cells possess membranous receptors for the octapeptide angiotensin II (AngII) whose density is substantially increased by in vitro differentiation. Incubation of differentiated N1E-115 cells with AngII produced a rapid decrease in receptor density, but did not alter the affinity of these receptors for either 125I-AngII or the high-affinity antagonist 125I-[Sarc1,Ile8]-AngII. This apparent down-regulation was dose related with an ED50 of 1 nM, and maximal decreases of approximately 90% were obtained with 100 nM AngII. Receptor loss from differentiated cell membranes was unaffected by incubations of membranes obtained from agonist-exposed cells with non-hydrolyzable analogues of GTP for 60 min at 37 degrees C to ensure dissociation of the ligand. Partial loss of AngII receptors was apparent within 5 min of agonist exposure, whereas maximal declines were not observed until 30 min. This temporal pattern resulted from a preferential decrease in the AT1 receptor subtype during the first 5 min, followed by a decline in both AT1 and AT2 receptors with longer periods of agonist exposure. The loss of membranous receptors was reversible with partial recovery observed after 4 h, and with nearly full recovery observed 18 h after exposure of the cells to AngII. However, the long-term recovery of receptor density was blocked by the protein synthesis inhibitor, cycloheximide. The heptapeptide angiotensin III produced a similar down-regulation of receptors, and the high-affinity antagonist [Sarc1,Thr8]-AngII blocked agonist-induced down-regulation. Finally, the apparent loss of cell surface AngII receptors decreased the ability of AngII to stimulate cyclic GMP production within intact N1E-115 cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Regulation of protease nexin-1 expression in cultured Schwann cells is mediated by angiotensin II receptors

“…The maximal effect was reached at 9 hr of incubation (97% of reduction), and after this time point, PN-1 mRNA slowly increased, returning to basal levels after 24 hr of renin application. It has been recently shown that a rapid decrease in Ang II receptor density (90% within 30 min) takes place via receptor internalization following incubation of neuroblastoma cells with Ang II (Reagan et al, 1993). This process of desensitization could thus explain why the effect caused by renin on PN-1 expression is observed only within a narrow time window.…”

Ability of angiotensin II to modulate striatal dopamine release via the AT1 receptor in vitro and in vivo

“…Abdellatif et al, 1991;Kuttan & Sim, 1993;Reagan et al, 1993). It should be noted, however, that the time course of the apparent desensitization of the response was markedly different between the two preparations and it could not be ruled out that at least a component of the apprent desensitization was due to a depletion of neuronal dopamine levels.…”

Importance of Input Perturbations and Stochastic Gene Expression in the Reverse Engineering of Genetic Regulatory Networks: Insights From an Identifiability Analysis of an In Silico Network

“…With few exceptions (Davidson et al 2002;Lee et al 2002;Shen-Orr et al 2002), most known examples of transcriptional regulation consist of only a few interacting genes (Almagor and Paigen 1988;Reagan et al 1993;Alberts et al 1994;Reinitz and Sharp 1995;Meyer and Schmidt 1997;Ouali et al 1997;Herdegen and Leah 1998;Cherry and Adler 2000;Gardner et al 2000;Ramakrishnan et al 2002). There are few alternatives for constructing biologically relevant networks that contain large numbers of genes other than by assembling several known regulatory motifs.…”